Joseph Todisco is CEO at CorMedix Inc. (CRMD). They have made 10 open-market trades across 2 companies since 2019, most recently 2026-06-22.
CIK 0001774807
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
7 open-market purchases totalling $560K since 2019, against 3 sales. Across 7 scored buys the stock is down 1.9% at ninety days, and 4.4 points behind the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 14% | 29% | 71% |
| Avg Move | -8.4% | -10.4% | -1.9% |
| Alpha | -6.5% | -4.1% | -4.4% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CRMD | SELL · 10b5-1 | 2025-12-18 | 2025-12-19 | $12.00 | $360K | +1.2% | -42.8% | -47.5% |
| CRMD | SELL | 2025-09-12 | 2025-09-12 | $13.00 | $650K | -12.5% | -17.7% | -8.6% |
| CRMD | BUY | 2024-03-13 | 2024-03-14 | $3.74 | $101K | -2.4% | +27.8% | +18.5% |
| CRMD | BUY | 2023-09-08 | 2023-09-08 | $3.71 | $37K | -4.7% | -7.6% | -6.3% |
| CRMD | BUY | 2022-11-15 | 2022-11-16 | $3.82 | $76K | +8.2% | +4.6% | +11.3% |
| CRMD | BUY | 2022-08-24 | 2022-08-25 | $3.92 | $18K | -7.3% | -25.8% | +3.9% |
| CRMD | BUY | 2022-05-16 | 2022-05-17 | $3.38 | $34K | -18.4% | -28.2% | +8.7% |
| AMRX | SELL | 2021-12-02 | 2021-12-03 | $4.10 | $6K | -0.5% | +16.6% | -0.5% |
| AMRX | SELL | 2021-03-15 | 2021-03-17 | $6.82 | $496K | +1.3% | -12.0% | -14.8% |
| AMRX | BUY | 2020-02-28 | 2020-03-03 | $3.62 | $145K | -23.5% | -23.0% | +20.2% |
| AMRX | BUY | 2019-05-13 | 2019-05-13 | $9.88 | $148K | -10.4% | -20.5% | -69.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.